TrialClinical pharmacokinetics2026

TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16).

Marian Klose et al.PubMed ↗Publisher ↗

No numbers read from the abstract.